4d Pharma Plc

4d Pharma (DDDD)

[ADVERT]
Company name:4d Pharma Plc
EPIC:DDDDTrading Currency:GBX
Market Sector:ASM6ISIN:GB00BJL5BR07
Market Segment:AMSMShare Type:DE
WWW Address:http://www.4dpharmaplc.com/Description:ORD 0.25P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 83.50 images.advfn.com/imagesnew/2/gb/down -0.9 [-1.07] 83.50 84.20 85.50 88.40 83.50 633,553
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 150.55 180.30 0.08 -22.80 - - - 183.00 - 48.00

4d Pharma Key Figures

(at previous day's close)
Market Cap.150.55m
Shares In Issue180.30m
Prev. Close84.40
PE Ratio- 
Dividend Yield-%
EPS - basic-22.80p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-12.58p
Return On Equity (ROE)-92.43%
Operating Margin-5,682.77%
PEG Factor- 
EPS Growth Rate37.96%
Dividends PS Growth Rate-%
Net Debt-1.32m
Gross Gearing21.04%
Quick Assets16.61m
Net Working Capital10.45m
Intangibles / Fixed Assets75.73%
Turnover PS0.30p
Pre-Tax Profit PS-16.83p
Retained Profit PS-14.34p
Cash PS4.87p
Net Cash PS1.29p
Net Tangible Asset Value PS *7.73p
Net Asset Value PS15.51p
Spread0.70 (0.83%) 

4d Pharma Balance Sheet

L^DDDD:Liabilities+EQL^DDDD:Assets

Share Price Performance

Sample Period HighLow
1 week90.9083.50
4 weeks100.4081.40
12 weeks109.0081.40
1 year183.0048.00

Share Price Chart (5 years)

4d Pharma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week87.40-3.90-4.4683.501.1686.11
4 weeks96.20-12.70-13.2081.401.0287.18
12 weeks92.60-9.10-9.8381.401.2194.82
26 weeks127.00-43.50-34.2581.402.05115.25
1 year50.2033.3066.3348.002.71112.74
3 years155.00-71.50-46.1323.501.3197.51
5 years710.00-626.50-88.2423.500.81102.45

4d Pharma Key Management Ratios

4d Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 4.56 
Tobin's Q Ratio (excl. intangibles)7.92 
Dividend Yield-%
Market-to-Book Ratio5.38 
Price-to-Pre-Tax Profit PS-4.96 
Price-to-Retained Profit PS-5.82 
Price-to-Cash Flow PS-6.64 
Price-to-Sales PS281.93 
Price-to-Net Tangible Asset Value PS10.80 
Price-to-Cash PS17.16 
Net Working Capital PS5.80 
Price Pct to Working Capital PS14.41%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

4d Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio3.45%
Debt-to-Equity Ratio0.04 
Debt-to-Equity Ratio (excl. Intgbl)0.07 
Debt-to-Equity Market Value0.01 
Net Gearing-3.74%
Net Gearing (excl. Intangibles)-6.19%
Gross Gearing21.04%
Gross Gearing (excl. Intangibles)34.82%
Gearing Under 1 Year18.22%
Gearing Under 1 Year (excl. Intgbl)30.16%
Assets/Equity1.27 
Cash/Equity31.37 
(Liquidity Ratios)
Net Working Capital to Total Assets29.50%
Current Ratio2.62 
Quick Ratio (Acid Test)2.57 
Liquidity Ratio1.36 
Cash & Equiv/Current Assets51.92%
(Solvency Ratios)
Enterprise Value142.77m
CFO/Sales-42.46 
CFO/Attributable Profit- 
CFO/Assets-0.64 
CFO/Debt-3.04 
Total Debt/Equity Market Value0.05 
Total Debt/Sales13.95 
Total Debt/Pre-Tax Profit-0.25 
Total Debt7.45m
Total Debt/Net Current Assets0.71%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-14.26%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs5 
Beta (60-Mnth)Beta (36-Mnth)
0.07720.0476

4d Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-104.75%
Return On Assets (ROA)-78.31%
Net Profit Margin-4,841.39%
Assets Turnover0.02 
Return On Equity (ROE)-92.43%
Return On Investment (ROI)-96.97%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-4,841.39%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.02 
Fixed Assets Turnover0.03 
Current Assets Turnover0.04 
Net Working Capital Turnover 
Inventory Turnover2.18 
(Other Operating Ratios)
Total Assets-to-Sales61.83 
Debtors-to-Sales1,429.21%
Debt Collection Period5,216.63Days

4d Pharma Dividends

Sorry No Data Available

4d Pharma Fundamentals

 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
turnover------0.53-m
pre tax profit-23.99--28.44--29.43--30.35-m
attributable profit-19.39--24.29--23.69--25.85-m
retained profit-19.39--24.29--23.69--25.85-m
eps - basic (p)-31.41 -36.17 -36.75 -22.80 
eps - diluted (p)-31.41 -36.17 -36.75 -22.80 
dividends per share- - - - 

4d Pharma Balance Sheet

 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
L^DDDD:Liabilities+EQL^DDDD:AssetsL^DDDD:Liabilities+EQL^DDDD:AssetsL^DDDD:Liabilities+EQL^DDDD:AssetsL^DDDD:Liabilities+EQL^DDDD:Assets
 31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
ASSETS
fixed assets fixed assets5.216.70%4.879.25%5.1616.86%4.4912.69%m
intangibles intangibles14.6718.88%14.4527.46%13.9945.70%14.0339.60%m
fixed investments fixed investments38.1349.05%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks0.250.33%0.290.55%0.200.65%0.290.82%m
debtors debtors7.609.78%16.9532.23%7.4324.27%7.8422.12%m
cash & securities cash & securities11.8715.26%16.0530.52%3.8412.53%8.7824.77%m
TOTAL77.74100%52.61100%30.61100%35.42100%m
LIABILITIES
creditors - short creditors - short4.986.41%5.189.84%6.2620.45%6.4518.22%m
creditors - long creditors - long2.973.82%1.673.17%2.016.56%1.002.82%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL7.9510.23%6.8413.01%8.2727.01%7.4521.04%m
EQUITY
ord cap, reserves ord cap, reserves69.7989.77%45.7686.99%22.3472.99%27.9778.96%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL69.7989.77%45.7686.99%22.3472.99%27.9778.96%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

4d Pharma Cash Flow Statement

31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)
Operating CF-17.19-22.94-21.56-22.67m
Pre-Financing CF-16.784.20-11.84-22.85m
Retained CF-16.804.19-12.224.94m

4d Pharma Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
LSE
DDDD
4d Pharma
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210805 11:43:40